Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-FR
Language English French
Date Updated 2019-12-21 2018-09-08
Drug Identification Number 02393239 02393239
Brand name APO-LAMIVUDINE HBV APO-LAMIVUDINE HBV
Common or Proper name LAMIVUDINE LAMIVUDINE
Company Name APOTEX INC APOTEX INC
Ingredients LAMIVUDINE LAMIVUDINE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 60 BTL 60 BTL
ATC code J05AF J05AF
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-07-04 2019-07-04
Actual discontinuation date 2019-12-20
Remaining supply date 2019-12-20 2019-07-04
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments